Interpretation of WHO Guidelines on tuberculosis care and support

doi:10.19982/j.issn.1000-6621.20220409

Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (12): 1249-1252.doi: 10.19982/j.issn.1000-6621.20220409

• Interpretation of Standards • Previous Articles Next Articles

Interpretation of WHO Guidelines on tuberculosis care and support

Liu Eryong¹, Meng Qinglin¹, Wang Qian², Wang Jing¹, Zhou Lin¹()

¹Department of Tuberculosis Patients Care, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
²General Office, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

Received:2022-10-19 Online:2022-12-10 Published:2022-12-02
Contact: Zhou Lin E-mail:zhoulin@chinacdc.cn
Supported by:
Tuberculosis Prevention and Control Project Funded by the Central Government-Daily Operation of Tuberculosis Business(228711)

Abstract

Abstract:

In July 2022, the World Health Organization (WHO) published Guidelines on tuberculosis care and support. The patient centered care activities were introduced from various interventions such as social support, treatment management and digital health technology. Through the interpretation of the guideline, to introduce the contents to the readers and provide reference to patients’ care activities in China.

Key words: World Health Organization, Social support, Disease management, Guidebooks

CLC Number:

Liu Eryong, Meng Qinglin, Wang Qian, Wang Jing, Zhou Lin. Interpretation of WHO Guidelines on tuberculosis care and support[J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1249-1252. doi: 10.19982/j.issn.1000-6621.20220409

References 7

[1]	World Care Council. The Patients’ Charter for tuberculosis care. Geneva: World Care Council, 2006.
[2]	Hopewell PC. Updating the international standards for tuberculosis care. Int J Tuberc Lung Dis, 2014, 18(3): 253. doi:10.5588/ijtld.14.0035. doi: 10.5588/ijtld.14.0035 pmid: 24670556
[3]	World Health Organization. The WHO consolidated guidelines on tuberculosis. Module 4: treatment. Tuberculosis care and support. Geneva: World Health Organization, 2022.
[4]	World Health Organization. The WHO operational handbook on tuberculosis. Module 4: treatment-tuberculosis care and support. Geneva: World Health Organization, 2022.
[5]	刘二勇, 陈明亭, 周林, 等. 开展患者关怀行动提升结核病防治综合服务质量. 中国防痨杂志, 2022, 44(5): 433-437. doi:10.19982/j.issn.1000-6621.20220022. doi: 10.19982/j.issn.1000-6621.20220022
[6]	中国疾病预防控制中心结核病预防控制中心. 中国结核病患者关怀手册. 北京: 人民卫生出版社, 2021.
[7]	王前, 王嘉, 刘二勇, 等. 《中国结核病患者关怀手册》专家解读. 中国防痨杂志, 2022, 44 (1): 49-53. doi:10.19982/j.issn.1000-6621.20210613. doi: 10.19982/j.issn.1000-6621.20210613

[1]	Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397.
[2]	Wang Xiaomin, Chen Jinyun, Zeng Yuqin, Ma Quan, Kong Xingxing, Meng Jianzhou, Lu Shuihua. Interpretation of the third edition of WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1006-1022.
[3]	Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876.
[4]	Wang Senlu, Liu Nianqiang, Wang Xinqi, Cao Mingqin, Wang Le, Wang Xijiang. Development and effectiveness of “Xinjiang Model” for tuberculosis prevention and control [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 141-144.
[5]	Bao Liangliang, Wang Xinqi, Zhang Yan, Cao Mingqin. Qualitative evaluation of the implementation status of tuberculosis prevention and control in Southern Xinjiang Uygur Autonomous Region: qualitative interviews based on grounded theories [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 151-157.
[6]	Xia Hui, Zhao Yanlin. Interpretation of the World Health Organization’s Practical Manual on Tuberculosis Laboratory Strengthening (2022 Update) and consideration on strengthening tuberculosis laboratory network in China [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 458-463.
[7]	Fu Liang, Ren Tantan, Zhang Peize, Lu Shuihua. Interpretation of WHO consolidated guidelines on tuberculosis, Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 336-348.
[8]	Wang Zeming, Shen Adong. Interpretation of Social Organization Standard of Diagnosis of central nervous system tuberculosis in children [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 18-24.
[9]	Han Tingting, Liu Guizhen, Chen Qiuqi, Deng Guofang. Interpretation of Framework for collaborative action on tuberculosis and comorbidities [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 25-30.
[10]	Ultrasound Professional Committee of Tuberculosis Branch of Chinese Medical Association, Interventional Ultrasound Professional Committee of Interventional Physician Branch of Chinese Medical Doctor Association Danwei. Expert consensus on ultrasound diagnosis, classification and interventional therapy of tuberculous pleurisy (2022 Edition) [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 880-897.
[11]	Cheng Jun, Lu Wei. Interpretation of Guideline on tuberculosis infection prevention and control in primary health care institute [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 762-767.
[12]	ZHANG Hui, ZHAO Yan-lin. Strengthen multi-sectoral cooperation mechanism to further promote the tuberculosis prevention and control in China [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 115-119.
[13]	WANG Qian, WANG Jia, LIU Er-yong, CHEN Ming-ting, ZHOU Lin.. Expert interpretation of “Handbook of Care for Tuberculosis Patients in China” [J]. Chinese Journal of Antituberculosis, 2022, 44(1): 49-53.
[14]	Beijing Chest Hospital, Capital Medical University, Editorial Board of Chinese Journal of Antituberculosis. Expert consensus on the therapeutic drug monitoring of anti-tuberculosis drugs [J]. Chinese Journal of Antituberculosis, 2021, 43(9): 867-873.
[15]	. Guideline for clinical management of adverse reactions of bacillus Calmette-Guérin [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 532-538.

Interpretation of WHO Guidelines on tuberculosis care and support

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 7

Related Articles 15

Recommended Articles

Metrics

Comments